About this trial
This study aims to evaluate the effect of Continuous Adductor Canal Block only versus adding posterior knee block, known as the Infiltration between the Popliteal Artery and Capsule of the Knee (IPACK) block with Continuous Adductor Canal Block (CACB) after arthroscopic knee surgeries.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age from 21 to 65 years.
Both sexes.
American Society of Anesthesiologists (ASA) Physical Status Class I to II.
Patients with successful spinal anesthesia.
Disqualifiers
Declining to give written informed consent.
History of allergy to the medications used in the study.
Contraindications to regional anesthesia (including coagulopathy and local infection).
Polytrauma patients having lower limb fractures.
Trial design
Parallel
Treatments tested in this trial
Continuous adductor canal block
Other interventionPatients will receive continuous adductor canal block.
Continuous Adductor Canal Block with additional Infiltration between The Popliteal Artery and Capsule
Other interventionPatients will receive Continuous Adductor Canal Block with additional Infiltration between The Popliteal Artery and Capsule of The Knee
Treatment groups
Trial outcomes
Primary outcomes
Degree of pain
The degree of pain will be assessed using the Visual Analogue Scale (VAS). VAS score is determined by measuring the distance (mm) on the 10-cm line between the "no pain" anchor and the patient's mark, providing a range of scores from 0-100. No pain (0-4 mm), mild pain (5-44 mm), moderate pain (45-74 mm), and severe pain (75-100 mm).
Secondary outcomes
Total Nalbuphine consumption
Rescue analgesia will be given when VAS score ≥ 30 mm, in the form of IV injection of 10 mg Nalbuphine. Followed by reassessment of pain after 10 minutes, a second dose of Nalbuphine will be given if still VAS score ≥ 30 mm.
Straight leg rise
Straight leg rise (SLR) will be recorded.
Range of motion
Range of motion (ROM) will be recorded
Rate of complications
Rate of complications like falling will be recorded
Sponsors and contacts
Click on the lead sponsor to view all of their trials.